The Case for Early Treatment in Severe Aortic Stenosis (SAS) Patients: What the Latest Evidence Tells Us-Heart Teams and Referrers: How Can They Engage to Treat All SAS Patients and Address Capacity? Dr. David J. Cohen

Heart Teams and Referrers: How Can They Engage to Treat All SAS Patients and Address Capacity? Dr. David J. Cohen

Video Transcription

Video Summary

The talk discusses strategies for upstream management of aortic stenosis. Key insights include identifying asymptomatic patients who are actually symptomatic, and improving time from diagnosis to treatment significantly, as demonstrated by St. Francis Hospital's expedited TAVR procedures. The presentation emphasizes using technology, like software and AI, to identify candidates for valve interventions more efficiently. It details the Preview Valve study, screening for valve disease across the U.S. through pharmacies, and the role of an EKG system developed at Columbia University called ValveNet. The importance of streamlined processes and administrative support is highlighted for effective care delivery.

Keywords

aortic stenosis

TAVR procedures

ValveNet

Preview Valve study

upstream management